The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
The bipartisan pharmacy benefit manager bill, which was approved by a Senate committee, would make it illegal to charge health plans and payers more for a prescription drug than what PBMs reimburse to the pharmacy.
Considering how the gender pay gap works against women's ability to create long-term wealth, setting up auto-enrollment in a company plan is the best possible option to increase retirement planning equity, says a new survey.
"To bridge pay gaps in the workplace, employers must proactively build pay equity and increase transparency within their organization," says Tanya Jansen, cofounder of beqom.
Health and Human Services Secretary Xavier Becerra said a high number of ineligible claims contributed to a bottleneck in processing them and that legislative action is needed to deal with the high volume.
At a Senate hearing, Moderna CEO defended the price hike as the company anticipates added costs from shifting to a 10-dose vial to single doses as requested by pharmacies and doctors.
Employers, faced with high costs in treating obesity-related chronic conditions, may want to consider the importance of providing access to the emerging weight loss medications, particularly with more options soon available.
The feds sued to halt the deal earlier this year, calling it anticompetitive because Change, which would be merged with UnitedHealth's data and consulting business Optum Insight, has access to data from insurer customers.
The agency has increased employer mandate penalties under the Affordable Care Act for non-compliant large employers (50+ employees) that fail to offer affordable health coverage to 95% of its staff.
Because of the Inflation Reduction Act, Medicare will have the ability to negotiate lower prescription drug prices with manufacturers - and will release the negotiated fair prices for the first 10 drugs September 1.